Christian Stratz, MD, University Heart Center Freiburg · Bad Krozingen, Department of Cardiology and Angiology II, Suedring 15, 79189 Bad Krozingen, Germany, Tel.: +49 7633 402 0, Fax: +49 7633 402 2489, E-mail:
Thromb Haemost. 2016 Oct 28;116(5):941-948. doi: 10.1160/TH16-03-0191. Epub 2016 Aug 4.
Reticulated platelets are associated with impaired antiplatelet response to thienopyridines. It is uncertain whether this interaction is caused by a decreased drug exposure due to high platelet turnover reflected by elevated levels of reticulated platelets or by intrinsic properties of reticulated platelets. This study sought to investigate if the impact of reticulated platelets on early antiplatelet response to thienopyridines is mainly caused by platelet turnover as previously suggested. Elective patients undergoing coronary intervention were randomised to loading with clopidogrel 600 mg or prasugrel 60 mg (n=200). Adenosine diphosphate (ADP)-induced platelet reactivity was determined by impedance aggregometry before, at 30, 60, 90, and 120 minutes and at day 1 after loading. Immature platelet count was assessed as marker of reticulated platelets by flow cytometry. Platelet reactivity increased with rising levels of immature platelet count in both groups. This effect was more distinctive in patients on clopidogrel as compared to patients on prasugrel. Overall, immature platelet count correlated well with on-treatment platelet reactivity at all time-points (p < 0.001). These correlations did not change over time in the entire cohort as well as in patients treated with clopidogrel or prasugrel indicating an effect independent of platelet turnover (comparison of correlations 120 minutes/day 1: p = 0.64). In conclusion, the association of immature platelet count with impaired antiplatelet response to thienopyridines is similar early and late after loading. This finding suggests as main underlying mechanism another effect of reticulated platelets on thienopyridines than platelet turnover.
网织血小板与噻吩吡啶类药物抗血小板反应受损有关。目前尚不清楚这种相互作用是由于血小板高转化率(表现为网织血小板水平升高)导致药物暴露减少,还是由于网织血小板的固有特性所致。本研究旨在探讨网织血小板对噻吩吡啶类药物早期抗血小板反应的影响是否主要是由血小板转化率引起的,如之前所假设的那样。择期行冠状动脉介入治疗的患者随机分为氯吡格雷 600mg 负荷量组或普拉格雷 60mg 负荷量组(n=200)。在负荷前、负荷后 30、60、90 和 120 分钟以及第 1 天,通过阻抗法血小板聚集仪测定二磷酸腺苷(ADP)诱导的血小板反应性。通过流式细胞术评估幼稚血小板计数作为网织血小板的标志物。在两组中,随着幼稚血小板计数的升高,血小板反应性也随之增加。与普拉格雷组相比,氯吡格雷组的这种作用更为明显。总体而言,幼稚血小板计数与所有时间点的治疗中血小板反应性密切相关(p<0.001)。在整个队列以及接受氯吡格雷或普拉格雷治疗的患者中,这些相关性在所有时间点均无变化,表明其不受血小板转化率影响(在整个队列中比较 120 分钟/第 1 天的相关性:p=0.64)。结论:在负荷后早期和晚期,幼稚血小板计数与噻吩吡啶类药物抗血小板反应受损之间的相关性相似。这一发现提示网织血小板对噻吩吡啶类药物的作用除了血小板转化率外,还有另一种机制。